These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9595424)

  • 1. The Endothelin-A antagonist LU 135 252 supresses ischemic ventricular extrasystoles and fibrillation in pigs and prevents hypoxic cellular decoupling.
    Raschack M; Juchelka F; Rozek-Schaefer G
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S145-8. PubMed ID: 9595424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The selective endothelin-A-receptor antagonist LU 135.252 inhibits the direct arrhythmogenic action of endothelin-1.
    Merkely B; Szabó T; Gellér L; Kiss O; Horkay F; Raschack M; Juhász-Nagy A
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S314-6. PubMed ID: 11078407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel non-peptide selective endothelin A receptor antagonist LU 135,252 protects against myocardial ischaemic and reperfusion injury in the pig.
    Gonon AT; Wang QD; Shimizu M; Pernow J
    Acta Physiol Scand; 1998 Jun; 163(2):131-7. PubMed ID: 9648631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotection from ischemia and reperfusion injury by an endothelin A-receptor antagonist in relation to nitric oxide production.
    Gonon AT; Gourine AV; Pernow J
    J Cardiovasc Pharmacol; 2000 Sep; 36(3):405-12. PubMed ID: 10975600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin-A-receptor antagonist LU 135.252 inhibits the formation of ventricular arrhythmias caused by intrapericardial infusion of endothelin-1.
    Kiss O; Gellér L; Merkely B; Szabó T; Raschack M; Seres L; Zima E; Juhász-Nagy A; Horkay F
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S317-9. PubMed ID: 11078408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ET(A) receptor antagonist LU 135252 has no electrophysiological or anti-arrhythmic effects during myocardial ischaemia/reperfusion in dogs.
    Vágó H; Soós P; Zima E; Gellér L; Kékesi V; Andrási T; Szabó T; Juhász-Nagy A; Merkely B
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():223S-227S. PubMed ID: 12193091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective ETA receptor blockade prevents left ventricular remodeling and deterioration of cardiac function in experimental heart failure.
    Mulder P; Richard V; Bouchart F; Derumeaux G; Münter K; Thuillez C
    Cardiovasc Res; 1998 Sep; 39(3):600-8. PubMed ID: 9861302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of nitric oxide in cardioprotective effect of endothelin receptor antagonist during ischemia-reperfusion.
    Gourine AV; Gonon AT; Pernow J
    Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1105-12. PubMed ID: 11179053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin A receptor blockade causes adverse left ventricular remodeling but improves pulmonary artery pressure after infarction in the rat.
    Nguyen QT; Cernacek P; Calderoni A; Stewart DJ; Picard P; Sirois P; White M; Rouleau JL
    Circulation; 1998 Nov; 98(21):2323-30. PubMed ID: 9826321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal denervation suppresses ventricular arrhythmias during acute ventricular ischemia in pigs.
    Linz D; Wirth K; Ukena C; Mahfoud F; Pöss J; Linz B; Böhm M; Neuberger HR
    Heart Rhythm; 2013 Oct; 10(10):1525-30. PubMed ID: 23851058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of endothelin ETA receptor blocker LU 135252 on cardiac remodeling and survival in a hypertensive rat model of chronic heart failure.
    Xia QG; Reinecke A; Dorenkamp M; Daemen MJ; Simon R; Unger T
    Acta Pharmacol Sin; 2006 Nov; 27(11):1417-22. PubMed ID: 17049116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endothelin A receptor antagonist LU 135252 protects the myocardium from neutrophil injury during ischaemia/reperfusion.
    Gonon AT; Wang QD; Pernow J
    Cardiovasc Res; 1998 Sep; 39(3):674-82. PubMed ID: 9861311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of magnesium on ischemic and reperfusion arrhythmias in a canine model with diminished collateral blood flow.
    Euler DE
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):565-71. PubMed ID: 8547206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic ETA receptor blockade attenuates cardiac hypertrophy independently of blood pressure effects in renovascular hypertensive rats.
    Ehmke H; Faulhaber J; Münter K; Kirchengast M; Wiesner RJ
    Hypertension; 1999 Apr; 33(4):954-60. PubMed ID: 10205230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin and ischaemic arrhythmias-antiarrhythmic or arrhythmogenic?
    Sharif I; Kane KA; Wainwright CL
    Cardiovasc Res; 1998 Sep; 39(3):625-32. PubMed ID: 9861305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered endothelin-1 binding following balloon angioplasty of pig coronary arteries: effect of the ETA receptor antagonist, LU 135252.
    Dashwood MR; Noertersheuser P; Kirchengast M; Münter K
    Cardiovasc Res; 1999 Aug; 43(2):445-56. PubMed ID: 10536675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The orally active ET(A) receptor antagonist (+)-(S)-2-(4,6-dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphe nyl-propionic acid (LU 135252) prevents the development of pulmonary hypertension and endothelial metabolic dysfunction in monocrotaline-treated rats.
    Prié S; Leung TK; Cernacek P; Ryan JW; Dupuis J
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1312-8. PubMed ID: 9316840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifibrillatory effects of BRL-32872 in anesthetized Yucatan minipigs with regional myocardial ischemia.
    Gout B; Nichols AJ; Feuerstein GZ; Bril A
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):636-44. PubMed ID: 8569227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhalation of the ETA receptor antagonist LU-135252 selectively attenuates hypoxic pulmonary vasoconstriction.
    Petersen B; Deja M; Bartholdy R; Donaubauer B; Laudi S; Francis RC; Boemke W; Kaisers U; Busch T
    Am J Physiol Regul Integr Comp Physiol; 2008 Feb; 294(2):R601-5. PubMed ID: 18077516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LU 302 872 and its racemate (LU 224 332) show balanced endothelin-A/B receptor affinity, high oral activity, and inhibit human prostate tissue contractions.
    Raschack M; Göck S; Unger L; Hahn A; Amberg W; Jansen R; Alken P; Weber A; Hergenröder S
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S241-4. PubMed ID: 9595449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.